CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 37 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$91,000
-34.5%
13,5620.0%0.00%
Q3 2020$139,000
-4.8%
13,562
+17.1%
0.00%
Q2 2020$146,00011,5860.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
PFS Partners, LLC 6,000$2,3860.00%
ACADIAN ASSET MANAGEMENT LLC 383,178$1520.00%
TWO SIGMA INVESTMENTS, LP 113,911$45,2910.00%
OSAIC HOLDINGS, INC. 557$2210.00%
US BANCORP \DE\ 1,221$4850.00%
WELLS FARGO & COMPANY/MN 180,066$71,5940.00%
NORTHERN TRUST CORP 30,251$12,0280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,100$8400.00%
GEODE CAPITAL MANAGEMENT, LLC 95,656$38,2620.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders